InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
68,156.13
(
0.52%
)
Post# of 252706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 18008
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: DewDiligence post# 252273

Thursday, 06/20/2024 7:24:08 PM

Thursday, June 20, 2024 7:24:08 PM

Post# of 252706
Keep your eye on insurance coverage and side effects of LLY and NVO meds for weight loss, as well as GILD’s presentation at ADA conference beginning tomorrow, 6/21/2024. I have stayed out of LLY and NVO while enjoying our substantial gain in 7,550 shares of NVDA (mentioned in your WSJ story link; I purchased NVDA in 2009 at split adjusted basis of $0.434 per share). We also have 3200 shares of GILD that traded + >$5 per share today, exact reasons unknown.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up